Zymeworks Files 2024 Proxy Statement
Ticker: ZYME · Form: DEF 14A · Filed: Oct 29, 2024 · CIK: 1937653
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Zymeworks DEF 14A filed. Annual meeting Dec 10. Vote your shares!
AI Summary
Zymeworks Inc. filed its definitive proxy statement (DEF 14A) on October 29, 2024, for its annual meeting scheduled for December 10, 2024. The filing outlines the company's governance and proposals for shareholders, including the election of directors and other corporate matters. Zymeworks Inc. is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership and voting matters, enabling informed participation in corporate decisions at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine proxy filing providing information to shareholders and does not contain new material financial or operational information that would inherently increase risk.
Key Numbers
- 20241210 — Annual Meeting Date (Shareholders will vote on company matters on this date.)
- 20241029 — Filing Date (The date Zymeworks Inc. submitted its definitive proxy statement.)
Key Players & Entities
- Zymeworks Inc. (company) — Registrant
- 20241029 (date) — Filing Date
- 20241210 (date) — Annual Meeting Date
- 0001937653 (company) — Central Index Key
- DE (state) — State of Incorporation
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a definitive proxy statement, is filed by a company to provide shareholders with information about matters to be voted on at an upcoming shareholder meeting, such as the election of directors and executive compensation.
When is Zymeworks Inc.'s annual meeting scheduled?
Zymeworks Inc.'s annual meeting is scheduled for December 10, 2024.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on October 29, 2024.
What is Zymeworks Inc.'s industry classification?
Zymeworks Inc. is classified under Pharmaceutical Preparations [2834].
Where is Zymeworks Inc. incorporated?
Zymeworks Inc. is incorporated in Delaware (DE).
Filing Stats: 4,808 words · 19 min read · ~16 pages · Grade level 14.4 · Accepted 2024-10-29 16:06:51
Key Financial Figures
- $72,600 — gent and will pay fees of approximately $72,600 Canadian dollars to Kingsdale for the p
Filing Documents
- d869690ddef14a.htm (DEF 14A) — 746KB
- g869690g01n01.jpg (GRAPHIC) — 480KB
- g869690g04n04.jpg (GRAPHIC) — 15KB
- g869690g06v53.jpg (GRAPHIC) — 22KB
- g869690g12u76.jpg (GRAPHIC) — 467KB
- g869690g22m61.jpg (GRAPHIC) — 117KB
- g869690g22m62.jpg (GRAPHIC) — 115KB
- g869690g24e82.jpg (GRAPHIC) — 51KB
- g869690g35i40.jpg (GRAPHIC) — 28KB
- g869690g36g38.jpg (GRAPHIC) — 213KB
- g869690g51w79.jpg (GRAPHIC) — 24KB
- g869690g70r54.jpg (GRAPHIC) — 12KB
- g869690g85o00.jpg (GRAPHIC) — 35KB
- g869690g87c23.jpg (GRAPHIC) — 24KB
- g869690g87d52.jpg (GRAPHIC) — 60KB
- 0001193125-24-246527.txt ( ) — 2865KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 40 Explanatory Note 40 Discussion of Executive Compensation Practices 40 i Table of Contents Benefits and Perquisites 50 Potential Payments upon Termination or Change in Control 51 Summary Compensation Table 51 Outstanding Equity Awards at 2023 Year End 53 Pension Benefits 54 Non-qualified Deferred Compensation 54 Registered Retirement Savings Plan 54 401(k) Plan 54 Executive Employment Arrangements and Potential Payments upon Termination or Change in Control 54 Risk Management 61 Equity Compensation Plan Information 62 Pay Versus Performance 63 DIRECTOR COMPENSATION 67 Cash Compensation for Directors 68 Equity Compensation for Directors 69 Expense Reimbursement 69 Director Compensation Table 69 Compensation Committee Interlocks and Insider Participation 70 OTHER MATTERS 71 Stockholder Proposals or Director Nominations for 2025 Annual Meeting 71 Availability of Bylaws 71 2023 Annual Report 71 APPROVAL 73 ii Table of Contents QUESTIONS AND ANSWERS Proxy Materials Why am I receiving these materials? Our board of directors ( Board of Directors ) is furnishing these materials in connection with our Meeting to be held on December 10, 2024. You are invited to attend the Meeting and are entitled and requested to vote on the business items described in this proxy statement ( proxy statement ). This proxy statement is furnished in connection with the solicitation of proxies by or on behalf of management and the Board of Directors. This proxy The Notice of Internet Availability of Proxy Materials (the Notice of Internet Availability ) containing instructions on how to access this proxy statement, the accompanying notice of annual meeting and f